Genemod

Genemod

Private
Seattle, WashingtonEnterprise Softwarehttps://genemod.net/

Last Round

Seed

May 4, 2023

Total Funding Raised

$6.2M

Momentum Score

25 /100

Company Overview

Genemod is a SaaS company that provides a cloud-based laboratory management software designed to streamline lab operations and accelerate scientific workflows for life science teams.

Sector

Enterprise Software

Verticals

Vertical SaaS, Workflow Automation, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Subscription SaaS, Government Contracts, Services & Consulting, Freemium

AI Layer

Non-AI

Keywords

LIMSlaboratory information management systemELNelectronic lab notebooklabtechlab data managementlife sciences softwarelab workflow automationsample managementlab inventory managementdigital lab notebookresearch reproducibilitybiopharma software21 CFR Part 11 compliancedata migration services

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Genemod Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Genemod Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
SeedMay 4, 2023
SeedOct 13, 2020

Key People

Founding team and executive leadership

Jin Choe

CTO Co-Founder

Founding Team

Jacob Lee

Co-Founder CEO

Founding Team

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 8, 2026

    Added Niedenthal Emotions Lab as a customer.

  • Dec 8, 2025

    Genemod, Inc. has integrated with Third Wave Analytics, Inc. The partnership was announced in the article's title, but the article body provides no further details.

Genemod Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Genemod Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Genemod's valuation, stock price, and market status.

Firmographic Details

HeadquartersSeattle, Washington
Employee Range9
Year Founded2017
Last FundingMay 4, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.